Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded a decrease of -50.35%. However, over the last six months, the performance has been stronger by -69.24%. The price of VKTX decreased -28.54% over the last 30 days. And in the last five days, it has fallen by -16.44%.
Viking Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $81.86 on 05/07/24, while the lowest price for the same period was registered at $20.27 on 04/08/25.
52-week price history of VKTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Viking Therapeutics Inc’s current trading price is -75.59% away from its 52-week high, while its distance from the 52-week low is -1.43%. The stock’s price range during this period has varied between$20.27 and $81.86. The Viking Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 6.01 million for the day, a figure considerably higher than their average daily volume of 4.57 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Viking Therapeutics Inc (VKTX) has experienced a quarterly decline of -53.02% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.24B and boasts a workforce of 36 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 36.83, with a change in price of -42.99. Similarly, Viking Therapeutics Inc recorded 4,277,616 in trading volume during the last 100 days, posting a change of -68.27%.
VKTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VKTX Stock Stochastic Average
As of today, Viking Therapeutics Inc’s raw stochastic average for the last 50 days stands at 2.38%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 3.36%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 7.78% and 11.86%, respectively.
